Viewing Study NCT04454905


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2025-12-26 @ 1:57 AM
Study NCT ID: NCT04454905
Status: UNKNOWN
Last Update Posted: 2023-04-19
First Post: 2020-06-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module